CD BioSciences Launches New Range of In Vivo Imaging Reagents for Scientific Research

CD Biosciences Launches Substrate-Chromogens for Immunohistochemistry

CD Biosciences Announces Expanded Capabilities for Mechanistic Target of Rapamycin Research in Diabetes and Metabolism

CD BioSciences has announced the launch of its comprehensive research solutions for the scientific community to gain insights into glucose homeostasis.

Embedding Resins and Kits for Electron and Light Microscopy

CD BioSciences Launches New 3D Tissue Imaging Services

CD BioSciences Launches New Services to Study Catabolism in Diabetes

CD BioSciences has announced a series of new solutions on mitotic catastrophe.

CD BioSciences introduced its new services based on super-resolution imaging technology for customers.

CD BioSciences has recently launched its new services based on immunofluorescence technology.

CD BioSciences has recently launched a suite of research solutions to assist researchers in the study of Type III cell death.

CD BioSciences has recently launched its new Time-Lapse Imaging services to assist researchers in a range of fields.

CD BioSciences has recently launched a suite of research solutions to support scientists studying of cell death, specifically Microautophagy.

CD BioSciences has recently launched a suite of research solutions to support scientists in the study of cell death.

CD BioSciences has recently announced the launch of Nanoparticles Imaging Technology in support of research applications.

CD BioSciences has recently announced the launch of Fluorescence Correlation Spectroscopy.

CD BioSciences has recently launched comprehensive research solutions for studying cell death, particularly the apoptotic cell death.